Wordt geladen...

Use of Sitagliptin With Closed-Loop Technology to Decrease Postprandial Blood Glucose in Type 1 Diabetes

BACKGROUND: Postprandial hyperglycemia poses a challenge to closed-loop systems. Dipeptidyl peptidase-4 (DPP-4) inhibitors, like sitagliptin, reduce postprandial glucose concentrations in patients with type 2 diabetes. The objective of this study was to assess sitagliptin’s role in type 1 diabetes (...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Diabetes Sci Technol
Hoofdauteurs: Underland, Lisa J., Ilkowitz, Jeniece Trast, Katikaneni, Ranjitha, Dowd, Amy, Heptulla, Rubina A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: SAGE Publications 2017
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5505438/
https://ncbi.nlm.nih.gov/pubmed/28349708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296817699847
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!